I am in a drug study at the University of Michigan for Alemtuzumab(campath,MabCampath) against Rebif.
I was just wondering if anyone else was on the alemtuzumab and how they were doing on it. I was picked for the Rebif and have had 2 relapses in the 4 months that I have been in the study, but I have been on Rebif since I was diagnosed in 2006. Just wondering if it would be worth staying in the study to get the alemtuzumab after my two years in the trial are up, or if I should I explore other options.
Tysabri scares me to death so I am trying to avoid that. I just had an MRI of the brain, T Spine, and C Spine done.
Any information could help my decision.